News

Brainstorm To Announce Second Quarter Financial Results And Provide A Corporate Update
Call Scheduled for August 14, 2025, at 8:30 AM Eastern Time ...
Knight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin America
ZYNYZ® is marketed by Incyte in the United States. In 2017, Incyte entered into an exclusive collaboration and license agreement with MacroGenics, Inc. for global rights to retifanlimab. ZYNYZ® is a ...
News-Medical.Net1d
New microscope system reveals molecular activity deep in the brain tissue
Both for research and medical purposes, researchers have spent decades pushing the limits of microscopy to produce ever ...
PharmiWeb2d
Global Cell Isolation Market to Grow at 11% CAGR Driven by Cell Therapy and Biopharma Demand by 2030
The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030, driven by rising investments in ...
Health And Pharma4d
Novel Viral Immunotherapy SuperNova Gains FDA Fast Track Designation for Sarcoma
CLD-201 (SuperNova), a novel stem cell–based oncolytic virus therapy, has received FDA Fast Track designation for soft tissue ...
CURE7d
Oncolytic Virus Wins FDA Fast Track Designation in Soft Tissue Sarcoma
The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue ...
Cells: Hemostemix ACP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants
ACP-01 (VesCell™) produces signals like IL-8, VEGF, and angiogenin. They attract natural killer (NK) cells that suppress ...
BC Technology9d
STEMCELL Technologies Introduces STEMprep Tissue Dissociator System to Accelerate Research Discoveries
STEMCELL Technologies announced that it has commercially launched the STEMprep Tissue Dissociator System —a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, ...